Full Press Release Details
to Host Conference Call to Report Second Quarter 2008 Financial
Beijing - August 7, 2008 -
Sinovac Biotech Ltd. (Amex: SVA), a
vaccine-focused biotech company in China, today announced that it will host a
conference call on Wednesday, August 13, 2008 at 9:00 a.m. ET to review the
Company's second quarter financial results for the period ended June 30, 2008
and provide an update on recent corporate developments.
the conference call, please dial 1-877-407-4018 (USA) or 1-201-689-8471
(international). A replay of the call will be available from 12:00
p.m. ET on August 13 until August 27, 2008, at midnight. To access the
replay, please dial 1-877-660-6853 (USA) or 1-201-612-7415 (international) and
reference the account number 3055 and the access code 293426.
audio webcast of the call will also be available from the Investors section on
the corporate web site at www.sinovac.com. A webcast replay can be accessed on
the corporate website beginning August 13, 2008 and the replay will remain
available for 30 days.
Biotech Ltd. is a China-based biopharmaceutical company that focuses on the
research, development, manufacture and commercialization of vaccines that
protect against human infectious diseases. Sinovac's commercialized vaccines
include Healive (hepatitis A), Bilive (combined hepatitis A and B), Anflu
(influenza) and Panflu (H5N1). Sinovac is currently developing Universal
Pandemic Influenza vaccine and Japanese encephalitis vaccine. Additional
information about Sinovac is available on its website, http://www.sinovac.com.
To be added to our distribution list, please email: